help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HANSEN, E. F.
Right arrow Articles by DIRKSEN, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HANSEN, E. F.
Right arrow Articles by DIRKSEN, A.

Am. J. Respir. Crit. Care Med., Volume 163, Number 3, March 2001, 690-693

Peak Flow as Predictor of Overall Mortality in Asthma and Chronic Obstructive Pulmonary Disease

EJVIND FRAUSING HANSEN, JØRGEN VESTBO, KLAUS PHANARETH, AXEL KOK-JENSEN, and ASGER DIRKSEN

Department of Respiratory Medicine 223, H:S Hvidovre Hospital, Hvidovre; and Department of Respiratory Medicine Y, Gentofte Hospital, Hellerup, Denmark

Lung function is a strong predictor of overall mortality in asthma and chronic obstructive pulmonary disease (COPD). FEV1 is considered to be the "gold standard," whereas peak expiratory flow (PEF) is mostly used in absence of FEV1 measurements. We compared the predictive power of PEF and FEV1, measured after maximal bronchodilation, which included a short course of oral corticosteroids. The study population comprised 491 asthmatics and 1,095 subjects with COPD. Pulmonary function tests were performed between 1983 and 1988, and survival data were obtained by September 1997, when 127 asthmatics and 723 subjects with COPD had died. Predictors of survival were examined by Cox proportional hazards analyses. After controlling for age, smoking, sex, and body mass index, we found best PEF to be at least equal to best FEV1 as predictor of overall mortality in subjects with COPD. The predictive power of best PEF was in part maintained after controlling for best FEV1. In asthma, best FEV1 seemed to be a better predictor of mortality than best PEF. Despite close correlation to FEV1, PEF apparently provides independent prognostic information in patients with COPD. This may be due to PEF and FEV1 reflecting different components of COPD, i.e., chronic bronchitis, small airways disease, and emphysema. Furthermore, extrapulmonary components such as muscle mass and general "vigour" probably affect PEF to a greater extent than they affect FEV1.




This article has been cited by other articles:


Home page
 ChestHome page
V. Bellia, C. Pedone, F. Catalano, A. Zito, E. Davi, S. Palange, F. Forastiere, and R. A. Incalzi
Asthma in the Elderly: Mortality Rate and Associated Risk Factors for Mortality
Chest, October 1, 2007; 132(4): 1175 - 1182.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. N. Aggarwal, D. Gupta, and S. K. Jindal
The relationship between FEV1 and peak expiratory flow in patients with airways obstruction is poor.
Chest, November 1, 2006; 130(5): 1454 - 1461.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J Vestbo, R Pauwels, J A Anderson, P Jones, P Calverley, and on behalf of the TRISTAN study group
Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease
Thorax, April 1, 2005; 60(4): 301 - 304.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2001
Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 642 - 662.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society